BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 19052456)

  • 21. Breast cancer resistance protein and P-glycoprotein in 149 adult acute myeloid leukemias.
    Benderra Z; Faussat AM; Sayada L; Perrot JY; Chaoui D; Marie JP; Legrand O
    Clin Cancer Res; 2004 Dec; 10(23):7896-902. PubMed ID: 15585622
    [TBL] [Abstract][Full Text] [Related]  

  • 22. P-glycoprotein (MDR1/ABCB1) and breast cancer resistance protein (BCRP/ABCG2) restrict brain accumulation of the JAK1/2 inhibitor, CYT387.
    Durmus S; Xu N; Sparidans RW; Wagenaar E; Beijnen JH; Schinkel AH
    Pharmacol Res; 2013 Oct; 76():9-16. PubMed ID: 23827160
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of aripiprazole and its active metabolite dehydroaripiprazole on the activities of drug efflux transporters expressed both in the intestine and at the blood-brain barrier.
    Nagasaka Y; Oda K; Iwatsubo T; Kawamura A; Usui T
    Biopharm Drug Dispos; 2012 Sep; 33(6):304-15. PubMed ID: 22847220
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ixabepilone, a novel microtubule-targeting agent for breast cancer, is a substrate for P-glycoprotein (P-gp/MDR1/ABCB1) but not breast cancer resistance protein (BCRP/ABCG2).
    Shen H; Lee FY; Gan J
    J Pharmacol Exp Ther; 2011 May; 337(2):423-32. PubMed ID: 21262849
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Absence of both MDR1 (ABCB1) and breast cancer resistance protein (ABCG2) transporters significantly alters rivaroxaban disposition and central nervous system entry.
    Gong IY; Mansell SE; Kim RB
    Basic Clin Pharmacol Toxicol; 2013 Mar; 112(3):164-70. PubMed ID: 22958812
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HIV-1 Alters Intestinal Expression of Drug Transporters and Metabolic Enzymes: Implications for Antiretroviral Drug Disposition.
    Kis O; Sankaran-Walters S; Hoque MT; Walmsley SL; Dandekar S; Bendayan R
    Antimicrob Agents Chemother; 2016 May; 60(5):2771-81. PubMed ID: 26902756
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Kinetic analysis of the cooperation of P-glycoprotein (P-gp/Abcb1) and breast cancer resistance protein (Bcrp/Abcg2) in limiting the brain and testis penetration of erlotinib, flavopiridol, and mitoxantrone.
    Kodaira H; Kusuhara H; Ushiki J; Fuse E; Sugiyama Y
    J Pharmacol Exp Ther; 2010 Jun; 333(3):788-96. PubMed ID: 20304939
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of efflux transporters in human ocular tissues.
    Chen P; Chen H; Zang X; Chen M; Jiang H; Han S; Wu X
    Drug Metab Dispos; 2013 Nov; 41(11):1934-48. PubMed ID: 23979916
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Closing the gaps: a full scan of the intestinal expression of p-glycoprotein, breast cancer resistance protein, and multidrug resistance-associated protein 2 in male and female rats.
    MacLean C; Moenning U; Reichel A; Fricker G
    Drug Metab Dispos; 2008 Jul; 36(7):1249-54. PubMed ID: 18378562
    [TBL] [Abstract][Full Text] [Related]  

  • 30. P-glycoprotein and breast cancer resistance protein expression and function at the blood-brain barrier and blood-cerebrospinal fluid barrier (choroid plexus) in streptozotocin-induced diabetes in rats.
    Reichel V; Burghard S; John I; Huber O
    Brain Res; 2011 Jan; 1370():238-45. PubMed ID: 21075088
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The prognostic value of P-glycoprotein (ABCB) and breast cancer resistance protein (ABCG2) in adults with de novo acute myeloid leukemia with normal karyotype.
    Damiani D; Tiribelli M; Calistri E; Geromin A; Chiarvesio A; Michelutti A; Cavallin M; Fanin R
    Haematologica; 2006 Jun; 91(6):825-8. PubMed ID: 16704962
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transport of anthelmintic benzimidazole drugs by breast cancer resistance protein (BCRP/ABCG2).
    Merino G; Jonker JW; Wagenaar E; Pulido MM; Molina AJ; Alvarez AI; Schinkel AH
    Drug Metab Dispos; 2005 May; 33(5):614-8. PubMed ID: 15703302
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A model of secreting murine mammary epithelial HC11 cells comprising endogenous Bcrp/Abcg2 expression and function.
    Tallkvist J; Yagdiran Y; Danielsson L; Oskarsson A
    Cell Biol Toxicol; 2015 Apr; 31(2):111-20. PubMed ID: 25791223
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regulation of expression and activity of multidrug resistance proteins MRP2 and MDR1 by estrogenic compounds in Caco-2 cells. Role in prevention of xenobiotic-induced cytotoxicity.
    Arias A; Rigalli JP; Villanueva SS; Ruiz ML; Luquita MG; Perdomo VG; Vore M; Catania VA; Mottino AD
    Toxicology; 2014 Jun; 320():46-55. PubMed ID: 24685904
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression analysis of MDR1, BCRP and MRP3 transporter proteins in different in vitro and ex vivo cornea models for drug absorption studies.
    Verstraelen J; Reichl S
    Int J Pharm; 2013 Jan; 441(1-2):765-75. PubMed ID: 23069916
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regulations of ABCB1 and ABCG2 expression through MAPK pathways in acute lymphoblastic leukemia cell lines.
    Tomiyasu H; Watanabe M; Sugita K; Goto-Koshino Y; Fujino Y; Ohno K; Sugano S; Tsujimoto H
    Anticancer Res; 2013 Dec; 33(12):5317-23. PubMed ID: 24324065
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Function of the ABC transporters, P-glycoprotein, multidrug resistance protein and breast cancer resistance protein, in minimal residual disease in acute myeloid leukemia.
    van der Pol MA; Broxterman HJ; Pater JM; Feller N; van der Maas M; Weijers GW; Scheffer GL; Allen JD; Scheper RJ; van Loevezijn A; Ossenkoppele GJ; Schuurhuis GJ
    Haematologica; 2003 Feb; 88(2):134-47. PubMed ID: 12604403
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of ATP-binding cassette membrane transporters in rodent and human sertoli cells: relevance to the permeability of antiretroviral therapy at the blood-testis barrier.
    Robillard KR; Hoque T; Bendayan R
    J Pharmacol Exp Ther; 2012 Jan; 340(1):96-108. PubMed ID: 21990609
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of BCRP and MDR-1 co-expression by quantitative molecular assessment in AML patients.
    Galimberti S; Guerrini F; Palumbo GA; Consoli U; Fazzi R; Morabito F; Santini V; Petrini M
    Leuk Res; 2004 Apr; 28(4):367-72. PubMed ID: 15109536
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Downregulation of mdr1 and abcg2 genes is a mechanism of inhibition of efflux pumps mediated by polymeric amphiphiles.
    Cuestas ML; Castillo AI; Sosnik A; Mathet VL
    Bioorg Med Chem Lett; 2012 Nov; 22(21):6577-9. PubMed ID: 23031592
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.